AKBA icon

Akebia Therapeutics

96 hedge funds and large institutions have $20.2M invested in Akebia Therapeutics in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 17 increasing their positions, 34 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less funds holding

Funds holding:

50% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 34

51% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 49

65% less capital invested

Capital invested by funds: $58.3M → $20.2M (-$38.1M)

Holders
96
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$212K
Puts
$65K
Net Calls
Net Calls Change

Top Buyers

1 +$2.59M
2 +$961K
3 +$655K
4
HF
HRT Financial
New York
+$380K
5
E
Ergoteles
New York
+$300K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$5.74M
2
$2.59M
3
$1.89M
4
$1.64M
5
$1.53M
6
$702K
7
$571K
8
$523K
9
$389K
10
$304K
11
$300K
12
$276K
13
$275K
14
$232K
15
$219K
16
$211K
17
$203K
18
$187K
19
$165K
20
$164K
21
$162K
22
$146K
23
$141K
24
$127K
25
$107K